An injection to cure diabetes

Stem-cell startup Viacell’s experimental therapy procedure (tested so far on mice) is to take pancreatic tissue from cadaver and isolate the stem cells, which matures into islet cells.

They are then cloned into massive quantities of “islet stem cells” which are then injected into the main artery to liver. These cells are believed to reside in the liver and possibly other organs and start producing insulin thereby curing diabetes.

They are also looking to isolate stem cells from newborns umbilical cord blood thereby avoiding controversy by (stupid) stem cell research opponents.

Viacell is collaborating with Genzyme Corp. to develop a therapy for Type 1 diabetes ( juvenile diabetes), estimated to go into human trials within two years.

Press release: Genzyme and ViaCell Announce Collaboration Agreement in Diabetes